Literature DB >> 5410895

Studies of delayed-action medication. V. Plasma levels and urinary excretion of four different dosage forms of chlorpromazine.

L E Hollister, S H Curry, J E Derr, S L Kanter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5410895     DOI: 10.1002/cpt197011149

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  11 in total

1.  Pharmacokinetics and relative bioavailability of levomepromazine after repeated administration of tablets and syrup.

Authors:  S G Dahl; R E Strandjord; S Sigfusson
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

Review 2.  Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs.

Authors:  L E Hollister
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  Destruction of chlorpromazine during absorption by rat intestine in vitro.

Authors:  S H Curry; A D'Mello; G P Mould
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

4.  Chlorpromazine: concentrations in plasma, excretion in urine and duration of effect.

Authors:  S H Curry
Journal:  Proc R Soc Med       Date:  1971-03

5.  Drug metabolism by the gastrointestinal mucosa.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

6.  The disposition and elimination of stereoisomeric pairs of thioridazine 5-sulfoxide in the rat.

Authors:  P W Hale; S Melethil; A Poklis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Oct-Dec       Impact factor: 2.441

7.  Chlorpromazine metabolism. IX. Pharmacokinetics of chlorpromazine following oral administration in man.

Authors:  L R Whitfield; P N Kaul; M L Clark
Journal:  J Pharmacokinet Biopharm       Date:  1978-06

8.  Inhibition of human neutrophil chemotaxis in vitro by phenothiazines and related compounds.

Authors:  B Björkstén; P G Quie
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

Review 9.  Emergency treatment of psychotic symptoms. Pharmacokinetic considerations for antipsychotic drugs.

Authors:  G V Milton; M W Jann
Journal:  Clin Pharmacokinet       Date:  1995-06       Impact factor: 6.447

10.  Destruction of chlorpromazine during absorption in the rat in vivo and in vitro.

Authors:  S H Curry; A D'Mello; G P Mould
Journal:  Br J Pharmacol       Date:  1971-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.